BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rajekar H, Vasishta RK, Chawla YK, Dhiman RK. Noncirrhotic portal hypertension. J Clin Exp Hepatol 2011;1:94-108. [PMID: 25755321 DOI: 10.1016/S0973-6883(11)60128-X] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Etzion O, Koh C, Heller T. Noncirrhotic portal hypertension: An overview. Clin Liver Dis (Hoboken) 2015;6:72-4. [PMID: 31040992 DOI: 10.1002/cld.497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Kmeid M, Liu X, Ballentine S, Lee H. Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data. Gastroenterology Res 2021;14:49-65. [PMID: 34007347 DOI: 10.14740/gr1376] [Reference Citation Analysis]
3 Ratnayake S, Ammar A, Rezvani R, Petersen G. Splenic Marginal Zone Lymphoma in the Setting of Noncirrhotic Portal Hypertension. J Investig Med High Impact Case Rep 2015;3:2324709615609385. [PMID: 26904707 DOI: 10.1177/2324709615609385] [Reference Citation Analysis]
4 Paka P, Huang B, Duan B, Li JS, Zhou P, Paka L, Yamin MA, Friedman SL, Goldberg ID, Narayan P. A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease. World J Nephrol 2018; 7(5): 96-107 [PMID: 30211028 DOI: 10.5527/wjn.v7.i5.96] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Marti J, Gunasekaran G, Iyer K, Schwartz M. Surgical management of noncirrhotic portal hypertension. Clin Liver Dis (Hoboken) 2015;5:112-5. [PMID: 31040963 DOI: 10.1002/cld.470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Kibrit J, Khan R, Jung BH, Koppe S. Clinical Assessment and Management of Portal Hypertension. Semin Intervent Radiol 2018;35:153-9. [PMID: 30087517 DOI: 10.1055/s-0038-1660793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
7 Lee H, Rehman AU, Fiel MI. Idiopathic Noncirrhotic Portal Hypertension: An Appraisal. J Pathol Transl Med. 2016;50:17-25. [PMID: 26563701 DOI: 10.4132/jptm.2015.09.23] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
8 Sinkala E, Zyambo K, Besa E, Kaonga P, Nsokolo B, Kayamba V, Vinikoor M, Zulu R, Bwalya M, Foster GR, Kelly P. Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial. Am J Trop Med Hyg 2018;98:1152-8. [PMID: 29436337 DOI: 10.4269/ajtmh.17-0637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Said SM. Commentary: Cor triatriatum dexter: A tale of 2 horns. JTCVS Tech 2020;4:259-60. [PMID: 34318035 DOI: 10.1016/j.xjtc.2020.09.005] [Reference Citation Analysis]
10 Hasbaoui BE, Rifai Z, Saghir S, Ayad A, Lamalmi N, Abilkassem R, Agadr A. Congenital hepatic fibrosis: case report and review of literature. Pan Afr Med J 2021;38:188. [PMID: 33995794 DOI: 10.11604/pamj.2021.38.188.27941] [Reference Citation Analysis]
11 Kmeid M, Zuo C, Lagana SM, Choi WT, Lin J, Yang Z, Liu X, Westerhoff M, Fiel MI, Affolter K, Choi EK, Lee H. Interobserver study on histologic features of idiopathic non-cirrhotic portal hypertension. Diagn Pathol 2020;15:129. [PMID: 33097074 DOI: 10.1186/s13000-020-01049-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]